SEC Form 4Coverage since Jun 8, 2026
$RMD insider trading
Over the last 12 months, Resmed insiders reported no purchases and 3 sales totaling $3.9M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $3.9M 3 events
- Events · 12m
- 3 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $RMD · 12Mvia TradingView
Top insiders · 12m
Farrell Michael J.Chairman and CEO2× · $2.1M
FARRELL PETER C—1× · $1.8M
All insider trades
3 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | FARRELL PETER CD | ▼ Sale | 8,000 | $225 | $1.8M | -13.2% | plan |
| Jul 7, 2026 | Farrell Michael J.Chairman and CEO · O·D | ▼ Sale | 4,991 | $218.55 | $1.1M | -1.1% | plan |
| Jun 8, 2026 | Farrell Michael J.Chairman and CEO · O·D | ▼ Sale | 4,991 | $193.96 | $968K | -1.1% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $RMD feed.